Liraglutide Effect and Action in our Diabetes - LEAD-6

Description:

The goal of the trial was to evaluate treatment with the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide compared with exenatide among patients with type 2 diabetes.